Average TAC and CYA levels did not differ between patients aged ≥60 and <59 years.
Mean MMF dose 1 year post-transplant was lower in patients aged ≥60 years.
Cytomegalovirus infection and acute rejection during follow-up did not differ.
There were no significant differences in creatinine level.